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Abstract 
The small GTP-binding protein Rad (RRAD, Ras associated with diabetes) is the 
founding member of the RGK (Rad, Rem, Rem2, and Gem/Kir) family that 
regulates cardiac voltage-gated Ca2+ channel function. However, its cellular and 
physiological functions outside of the heart remain to be elucidated.  Here we 
report that Rad GTPase function is required for normal bone homeostasis in 
mice, as Rad deletion results in significantly lower bone mass and higher bone 
marrow adipose tissue (BMAT) levels. Dynamic histomorphometry in vivo and 
primary calvarial osteoblast assays in vitro demonstrate that bone formation and 
osteoblast mineralization rates are depressed, while in vitro osteoclast 
differentiation is increased, in the absence of Rad.  Microarray analysis revealed 
that canonical osteogenic gene expression (Runx2, osterix, etc.) is not altered in 
Rad-/- calvarial osteoblasts; instead robust up-regulation of matrix Gla protein 
(MGP, +11-fold), an inhibitor of extracellular matrix mineralization and a protein 
secreted during adipocyte differentiation, was observed.  Strikingly, Rad 
deficiency also resulted in significantly higher marrow adipose tissue levels in 
vivo and promoted spontaneous in vitro adipogenesis of primary calvarial 
osteoblasts.  Adipogenic differentiation of wildtype calvarial osteoblasts resulted 
in the loss of endogenous Rad protein, further supporting a role for Rad in the 
control of BMAT levels.  These findings reveal a novel in vivo function for Rad 
and establish a role for Rad signaling in the complex physiological control of 
skeletal homeostasis and bone marrow adiposity. 
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surface/bone surface, ORO – Oil Red O, Rad – Ras associated with diabetes, 
RGK – Rem, Rad, Rem2, Gem/Kir, TRAP – tartrate resistant acid phosphatase 
Highlights 
 Rad GTPase deficiency in mice results in osteopenia, altering both 
osteoblast and osteoclast differentiation in vitro. 
 Rad loss promotes in vivo bone marrow adipose tissue accumulation and 
stimulates in vitro adipogenesis of primary calvarial osteoblasts. 
 Rad loss increases the expression of matrix Gla protein, an inhibitor of 
mineralization, without altering canonical osteoblast gene expression. 
 Adipogenesis results in reduced endogenous Rad, suggesting a potential 
linkage between Rad levels, bone density, and bone marrow adiposity. 
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1. Introduction 
Rad (RRAD, Ras associated with diabetes) is a monomeric G-protein that was 
originally identified as a gene up-regulated in the skeletal muscle of a subset of 
patients with type 2 diabetes [1] and is the founding member of the RGK (Rem, 
Rad, Rem2, and Gem/Kir) subfamily of Ras-related small GTPases [1-5]. The 
common structure for all RGK proteins consists of a conserved Ras-related core 
domain, a series of nonconservative amino acid substitutions within regions 
involved in guanine nucleotide binding and hydrolysis, a non-CAAX-containing C-
terminal extension, and large N-terminal extensions relative to other Ras family 
proteins [6, 7]. Although RGK proteins display modest intrinsic GTPase activity, 
recent studies have questioned whether RGK proteins are predominantly 
controlled via the canonical GTP/GDP regulatory cycle [7, 8], and no guanine 
exchange factor (GEF) or GTPase activating protein (GAP) regulatory proteins 
have been identified to date.  However, it is clear that both transcriptional and 
posttranscriptional control mechanisms, particularly phosphorylation, regulate 
RGK protein activity in response to a diversity of environmental stimuli [9-13]. 
Rad was initially identified as a gene overexpressed in the skeletal muscle of 
type II diabetic individuals [1], although analysis of Rad expression in Pima 
Indians and the Zucker diabetic rat model did not find such a correlation [14].  
Rad expression is also up-regulated in regenerating limb muscle following 
amputation in the newt [15], in the myogenic progenitor cell population during 
skeletal muscle regeneration [16], denervated mouse muscle [17], and in 
vascular smooth muscle cells following balloon injury [18].  We have recently 
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found that Rad protein levels are lowered in human patients with end-stage non-
ischemic heart failure [19]. In addition to these changes in Rad expression in 
muscle, Rad levels are also altered in other tissues that require further 
investigation. For instance, Rad expression is induced in the suprachiasmatic 
nucleus following light stimulation [20, 21], in human peripheral blood 
mononuclear cells after acute heat shock [22], in cirrhotic livers relative to normal 
livers [23], and in human placenta following hypoxia [24]. In each of these cases, 
the mechanism for up-regulation of Rad expression and its functional implications 
require further investigation. 
Rad function has primarily been studied in the heart, where Rad has been shown 
to inhibit L-type calcium channel activity [25, 26] and attenuate -adrenergic 
signaling [19, 26-28]; however, Rad is also expressed in non-excitable tissues 
[14], suggesting physiological roles for this G-protein beyond calcium channel 
regulation.  Indeed, recent work suggests that Rad deficiency can lead to 
increased cardiac fibrosis [29], which arises from excess deposition of 
extracellular matrix (ECM) in the heart [30]. Rad was found to inhibit connective 
tissue growth factor expression in cardiomyocytes through its association with 
CCAAT-enhancer binding protein- (C/EBP- to regulate ECM production [29].  
Together with a literature indicating that RGK proteins, through interactions with 
both calmodulin and 14-3-3 proteins, undergo regulated nuclear transport [31-
33], these data suggest that RGK proteins, including Rad, may play an 
underappreciated role in the regulation of gene expression. 
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RGK proteins have also been identified as novel regulators of cell differentiation 
[34-36].  Rem2, an RGK family member is highly expressed in embryonic stem 
cells and plays a key role in ectoderm differentiation and neuronal development 
[34, 35].  The observation that Rem2 may regulate cell differentiation was 
recently extended to include Rad [36]. Satija and colleagues recently reported 
that lithium treatment of human mesenchymal stem cells (MSCs) to enhance 
osteogenic differentiation elicited a robust increase in Rad expression [36].  
Notably, siRNA-mediated Rad silencing reversed the osteogenic priming effect of 
lithium [36]. Hence, Rad may play a role in the regulation of osteogenesis that 
requires further investigation. 
Mesenchymal stem cells (MSCs) present in the bone marrow are the precursors 
for osteoblasts, chondrocytes, and adipocytes [37, 38].  Interestingly, many 
conditions that can induce bone loss, such as estrogen insufficiency, anorexia, 
disuse, and hind limb unloading, are accompanied by increased bone marrow 
adipose tissue (BMAT) [39-43]. In patients with osteoporosis, bone marrow 
adiposity is significantly increased, and bone formation rates are inversely related 
to BMAT levels [44, 45]. One mechanism that has been proposed to explain the 
often inverse relationship between bone density and bone marrow adiposity is a 
shift in mesenchymal progenitors toward more adipogenic differentiation at the 
expense of osteoblast formation, but much remains to be determined [46].  
However, the transcriptional programs that drive MSCs to adopt these two cell 
fates are well characterized, with C/EBP-α and peroxisome proliferator-activated 
receptor γ2 (PPARγ2) initiating expression of genes associated with mature 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
adipocytes [47], and Runt-related transcription factor 2 (Runx2) and the 
downstream osteoblast-specific transcription factor osterix/Sp7 required for 
osteogenic differentiation [48-50].  Unexpectedly, and in contrast to white and 
brown adipocytes, bone marrow adipocytes were recently found to express 
osterix/Sp7 [51], suggesting that MSCs directed toward an osteogenic fate may 
be re-allocated toward an adipogenic one. While several Ras-related GTPases 
and mitogen activated protein kinases (MAPKs) have been demonstrated to 
contribute to proper osteoblast development [52-54], there is need for a deeper 
mechanistic understanding of the regulatory signaling pathways involved in 
osteogenesis versus adipogenesis, especially the signal transduction cascades 
controlling BMAT. 
Given the importance of the balance between osteogenesis and adipogenesis in 
human disease, we seek in the present study to characterize the effects of Rad 
deletion on bone homeostasis and bone marrow adiposity in vivo and on 
osteoblast function in vitro using global Rad-knockout (Rad-/-) mice.  We test the 
hypothesis that genetic deletion of Rad results in low bone mass through a 
decrease in bone formation by osteoblasts, and we postulate that Rad might be 
one of the elusive upstream regulators of the switch between osteogenesis and 
adipogenesis. 
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2. Materials and Methods 
2.1 Animals 
Mice lacking Rad expression (Rad-/-) were obtained from the Kahn laboratory at 
the Joslin Diabetes Center and have been described previously [55].  Rad-/- mice 
were backcrossed with C57/BL6 mice for 5 generations.  All experimental 
procedures and methods used were approved by the Institutional Animal Care 
and Use Committee of the University of Kentucky and conformed to the National 
Institutes of Health Guide for Care and Use of Laboratory Animals.  
The femora used in this study were obtained from male and female mice at four 
months of age.  Mouse spleen cells were isolated from two-month-old male mice 
for osteoclast differentiation assays.  Primary calvarial osteoblasts were isolated 
from pooled litters of three-day-old mice.   For fluorochrome labeling, mice were 
injected intraperitoneally with calcein (pH 7.4, 30 mg/kg, Sigma) at 7 and 2 days 
prior to sacrifice.  
2.2 Microcomputed tomography 
Femora were fixed in 10% neutral buffered formalin and transferred to 70% 
ethanol prior to scanning.  CT scanning was performed using a Scanco Model 
40 (Scanco Medical AG, Basserdorf, Switzerland) at 55 kV and 145 A, 0.3-
second integration time with a 10 m isotropic voxel size in plane and a 10 m 
thickness. The overall femur length was used to guide the cortical and trabecular 
analyses.  Specifically, the trabecular ROI ranged from just proximal of the distal 
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growth plate to 30% of the bone length as measured from the distal end.  The 
trabecular output variables included total volume (TV), bone volume (BV), bone 
volume fraction (BV/TV), connectivity density (Conn.D), structural model index 
(SMI), trabecular number (Tb.N), trabecular thickness (Tb.Th), trabecular spacing 
(Tb.Sp), apparent density (Ap.Dens), material density (Mat.Dens), specific bone 
surface (BS/BV), and degree of anisotropy (DA). Trabecular analyses utilized a 
sigma value of 0.8, support of 1, and threshold at 270.  Cortical data at the 
midshaft of the femur were also analyzed, including cortical bone area (Ct.Ar), 
total cross-sectional area (Tt.Ar), medullary area (Ma.Ar), cortical thickness 
(Ct.Th), and cortical area fraction (Ct.Ar/Tt.Ar). Cortical analyses utilized a sigma 
value of 1.5, support of 2, and threshold at 350.  CT analysis of the distal femur 
was limited to female animals, whereas CT analysis at the diaphysis to obtain 
cortical geometry was performed on femora from both male and female mice 
2.3 Mechanical testing 
Four-point bend testing was performed as previously described [56] to measure 
whole bone mechanical properties [57]. Briefly, the anterior surface of each 
femur was placed on two supports, and the femur was loaded at a rate of 2 
mm/min until failure.  Force-displacement curves allowed determination of 
structural properties including ultimate force, stiffness, displacement, and energy 
absorption for each specimen, and apparent material properties were derived 
using standard beam-bending equations for four-point bending. Diaphysis CT 
was used to normalize the mechanical properties.  The 0.2% offset criterion was 
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used to define yield points, and a custom MATLAB (Version 11) program was 
used for all mechanical analyses [56, 58]. 
2.4 Histology 
Femora were fixed in 10% neutral buffered formalin and embedded in methyl 
methacrylate. Thick sections (~80 m) were cut at mid-diaphysis using a 
diamond wire saw.  Thin sections (~4-10 m) were cut at the distal femur using a 
tungsten-carbide knife. 
For dynamic histomorphometry, the total surface and the surfaces with single 
and double labeling were measured along with the inter-label width on the 
periosteal and endocortical surfaces of cortical bone and on trabecular surfaces 
of the distal femur.  A value of 0.1 m per day was used for mineral apposition 
rate (MAR) when only one label was present to permit bone formation rate 
(BFR/BS) to be calculated. 
For static histomorphometry, thin sections from the distal femora were 
deplasticized in acetone and subjected to staining for tartrate-resistant acid 
phosphatase (TRAP) to quantify osteoclast surface (Oc.S/BS) as previously 
described [59] or Von Kossa stain for mineral with Macneal’s tetrachrome 
counterstain [60].  All the terminology and units used follow the recommendations 
of the Histomorphometry Nomenclature Committee of the American Society for 
Bone and Mineral Research [61]. 
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2.5 In vitro osteoclastogenesis assay 
Mouse spleen cells were prepared as previously described [62].  Spleen cells 
were cultured in untreated Petri dishes for 5 days in -MEM supplemented with 
10% FBS, 100 U/mL penicillin, 100 g/mL streptomycin, and 10 ng/mL 
macrophage colony stimulating factor (M-CSF).   Cells were then split into 24-
well plates (25,000 cells/well) in -MEM supplemented with 10% FBS, 100 U/mL 
penicillin, 100 g/mL streptomycin, 5 ng/mL M-CSF, and 50 ng/mL receptor 
activator of nuclear factor kappa-B ligand (RANKL), and cultured for 7 days prior 
to osteoclast differentiation analysis.  Tartrate-resistant acid phosphatase (TRAP) 
staining was performed (Takara, Cat No. MK300), and the number of TRAP-
positive multinucleated cells (MNCs, at least 3 nuclei) per well were counted. 
2.6 Calvarial osteoblast isolation and culture 
Primary neonatal mouse calvarial osteoblast cultures were established as 
previously described [63].  The primary osteoblasts were plated in 10 cm dishes 
and maintained in -MEM supplemented with 10% fetal bovine serum, 100 U/mL 
penicillin, and 100 g/mL streptomycin.  After 72 hours, the cells were split into 6 
well dishes at a density of 15,000 cells/cm2.  Upon confluence, cells were either 
maintained in growth media or switched to osteogenic media (MEM + 10% 
FBS, 5 mM -glycerophosphate, and 100 g/mL ascorbic acid) or adipogenic 
media (MEM + 15% FBS, 5 g/mL insulin, 50 M indomethacin, 0.5M IBMX, 
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and 1 M dexamethasone). The media was changed every third day until 
endpoint assays were performed.   
2.7 Alkaline phosphatase staining 
Alkaline phosphatase activity of calvarial osteoblasts was measured using the 
premixed BCIP/NBT solution (Sigma) according to the manufacturer’s 
instructions on day 7 of incubation in osteogenic media or adipogenic media.   
2.8 Alizarin Red S staining 
Calvarial osteoblast calcium deposition was measured using Alizarin Red S 
(ARS, Sigma) staining on day 28 of incubation in osteogenic media.  Cell 
monolayers were fixed with 10% neutral buffered formalin before incubation with 
0.02% ARS (pH 4.2) for 45 minutes in the dark at room temperature.  Cell 
monolayers were then washed several times with distilled water and imaged.  For 
quantification, ARS stain was solubilized using 10% acetic acid, neutralized with 
10% ammonium hydroxide, and centrifuged.  The optical density of the 
supernatant at 405 nm was measured using a plate reader. 
2.9 Oil Red O staining 
The presence of adipocytes in calvarial osteoblast cultures was determined using 
Oil Red O (ORO, Sigma) staining at day 14 in standard growth media.  A stock 
solution of 0.3% ORO in isopropanol was used to generate a working ORO 
solution by diluting 3 parts stock solution with 2 parts distilled water just before 
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each experiment.  Cell monolayers were fixed in 10% neutral buffered formalin 
and then incubated in 60% isopropanol for 5 minutes before staining with the 
working solution of ORO for 15 minutes.  Cell monolayers were then washed with 
distilled water, incubated with Harris Hematoxylin solution for one minute to 
counterstain nuclei, then washed and maintained in PBS for imaging.  
2.10 Western blotting 
Calvarial osteoblasts were harvested in ice cold lysis buffer (20 mM Tris-HCl, pH 
7.5; 250 mM NaCl; 10 mM MgCl2; 1% Triton X-100; and 1x protease inhibitor 
cocktail, Calbiochem) and subjected to SDS-PAGE and immunoblotting analysis 
using Goat anti-Rad (Everest BioTech) or Rabbit anti-Gapdh (Cell Signaling) 
primary antibody and peroxidase-conjugated mouse anti-goat IgG (Jackson 
ImmunoResearch) or donkey anti-rabbit (GE Healthcare) secondary antibody.  
Signals were developed using Hyglo chemiluminescent reagent (Denville 
Scientific) and detected using a ChemiDoc MP (Bio-Rad). 
2.11 Microarray  
Total RNA was isolated from confluent WT and Rad-/- calvarial osteoblast 
cultures using the standard Trizol and chloroform method, and RNA quality was 
assessed using RNA 6000 Nano-LabChip (Agilent).  The University of Kentucky 
microarray core facility performed labeling of the RNA and hybridization to the 
chip. Total RNA (100 ng per sample) was labeled and hybridized onto the 
Affymetrix Clariom D mouse array.  The arrays were hybridized for 16 hours at 
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45oC and 60 rpm.  The arrays were washed and stained on the Affymetrix 
Fluidics 450 station and scanned on the Affymetrix GeneChip7G scanner to 
quantify the signal intensity of hybridized probes.  Data were analyzed using the 
Affymetrix Command Console software.  
2.12 Reverse transcriptase-polymerase chain reaction 
For RT-PCR, cDNA was prepared from 1 g of total RNA using the RT2 First 
Strand Kit (Qiagen).  The following primers were utilized for RT-PCR: mouse 
matrix Gla protein (MGP), 5’-GGAGAAATGCCAACACCTTT-3’ (forward) and 5’-
CGAAACTCCACAACCAAATG-3’ (reverse) and 18S, 5’-TAGAGGGACAAGTGG 
CGTTC-3’ (forward) and 5’-CGCTGAGCCAGTCAGTGT-3’ (reverse). PCR 
products were amplified using DreamTaq Green (Thermo Scientific) and resolved 
on 1% agarose gels.  PCR products were imaged with Gel Logic 112  (Fisher 
Biotech), and band intensities were quantified using ImageJ.  
2.13 EchoMRI 
The body composition of live, unanesthetized mice was measured using an 
EchoMRI-100 whole body composition analyzer (Echo Medical System, Houston, 
TX). 
2.14 Statistics 
Statistical analysis was performed using Student’s t test, with p<0.05 considered 
significant, and all data are reported as mean +/- SEM. 
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3. Results 
3.1 Lower trabecular and cortical bone density in Rad-/- femora 
To explore the impact of Rad deficiency on bone density, WT and Rad-/- femora 
from both male and female mice were analyzed by microcomputed tomography 
(CT). Rad-/- femora from female mice exhibited a significantly lower trabecular 
bone volume fraction and trabecular number, with a parallel increase in 
trabecular spacing relative to WT controls (Figure 1A and Table 1).  A similar 
trend was observed in male Rad-/- femora (Figure 1A). Trabecular thickness was 
not significantly different from WT.  Rad-/- femora also exhibited a significantly 
lower cortical bone area and thickness than WT, whereas the medullary area 
was significantly higher when compared to WT controls (Figure 1B and Table 1). 
Taken together, these data suggest that Rad GTPase contributes to the 
maintenance of normal bone density. 
3.2 Rad-/- femora have altered mechanical properties 
Rad-/- femora displayed a significant mechanical phenotype, including a 
significantly lower cortical bone ultimate force, stiffness, work to yield, ultimate 
stress, and elastic modulus compared to femora from WT controls (Figure 2). 
Total displacement, toughness, and total strain were all significantly higher in the 
absence of Rad (Table 2). These data indicate that Rad loss results in a unique 
mechanical phenotype characterized by weaker and more elastic bones, which is 
consistent with the lower bone density evident from CT analysis. 
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Figure 1. Lower trabecular and cortical bone volume in the femora of Rad-/- 
mice 
 
A) Representative images from CT analysis of trabecular bone at the distal femora of 
WT and RadKO mice with accompanying quantification of the trabecular bone volume 
fraction (BV/TV).  B) Representative images from CT analysis of cortical bone at the 
midshaft of WT and RadKO mouse femora with corresponding quantification of the 
cortical bone area fraction (Ct.Ar/Tt.Ar).  N=5-15 mice per group, 4 months of age. ** 
p<0.01, *** p<0.001 compared to WT by Student’s t test. 
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Table 1. Trabecular and cortical geometry of 4-month-old female mouse 
femora 
Distal Femur Wildtype (N=5) Rad-/- (N=5) 
TV (mm3) 3.26 +/- 0.18 4.65 +/- 0.06 *** 
BV (mm3) 0.316 +/- 0.043 0.224 +/- 0.038 
BV/TV (%) 9.60 +/- 0.88 4.81 +/- 0.80 ** 
Conn.D 109.32 +/- 8.76 27.06 +/- 6.16 *** 
SMI 2.43 +/- 0.09 3.20 +/- 0.08 *** 
Tb.Th (mm) 0.045 +/- 0.002 0.047 +/- 0.002 
Tb.N (1/mm) 3.49 +/- 0.12 2.72 +/- 0.11 ** 
Tb.Sp (mm) 0.287 +/- 0.008 0.368 +/- 0.015 ** 
Ap.Dens 278.56 +/- 9.72 204.50 +/- 11.25 ** 
BS/BV 61.31 +/- 2.21 63.38 +/- 3.30 
DA 1.34 +/- 0.04 1.35 +/- 0.03 
Femoral Midshaft Wildtype (N=5) Rad-/- (N=5) 
Ct.Ar (mm2) 0.964 +/- 0.018 0.789 +/- 0.016 *** 
Tt.Ar (mm2) 1.452 +/- 0.013 1.806 +/- 0.031 *** 
Ma.Ar (mm2) 0.489 +/- 0.010 1.018 +/- 0.022 *** 
Ct.Th (mm) 0.257 +/- 0.007 0.183 +/- 0.003 *** 
Ct.Ar/Tt.Ar (%) 66.34 +/- 0.79 43.67 +/- 0.60 *** 
** p<0.01, *** p<0.001 compared to WT using Student’s t test 
 
 
Figure 2. Rad deletion results in altered mechanical properties 
 
Figure 2. Quantification of mechanical properties from four-point bending analysis of 
mouse femora. N=13-15 mice per genotype, 4 months of age. *** p<0.001 compared to 
WT by Student’s t test. 
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Table 2. Whole bone structural and estimated material mechanical 
properties from femoral four-point bending  
Femur Wildtype (N=13) Rad-/- (N=15) 
Yield Force (N) 24.50 +/- 1.20 7.99 +/- 0.41 *** 
Ultimate Force (N) 28.86  +/- 1.57 17.54 +/- 0.72 *** 
Displacement to Yield (mm) 186.93 +/- 4.16 103.98 +/- 5.76 *** 
Postyield Displacement (mm) 165.85 +/- 18.39 810.28 +/- 87.62 *** 
Total Displacement (mm) 352.77 +/- 18.45 914.26 +/- 88.08 *** 
Stiffness (N/mm) 195.73 +/- 7.99 127.17 +/- 5.38 *** 
Work to Yield (mJ) 2.52 +/- 0.16 0.51 +/- 0.05 *** 
Postyield Work (mJ) 4.46 +/- 0.49 10.17 +/- 0.75 *** 
Total Work (mJ) 6.98 +/- 0.52 10.68 +/- 0.75 *** 
Yield Stress (MPa) 258.67 +/- 13.54 74.75 +/- 4.87 *** 
Ultimate Stress (MPa) 301.56 +/- 12.34 160.64 +/- 4.52 *** 
Strain to Yield (m) 20380.8 +/- 935.8 11527.4 +/- 533.2 *** 
Total Strain (m) 38517.2 +/- 2681.7 101673.0 +/- 9722.0 *** 
Elastic Modulus (GPa) 14.17 +/- 0.63 7.73 +/- 0.21 *** 
Resilience (MPa) 2.94 +/- 0.26 0.53 +/- 0.05 *** 
Toughness (MPa) 8.29 +/- 0.91 10.76 +/- 0.74 * 
* p<0.05, *** p<0.001 compared to WT using Student’s t test 
 
3.3 Rad deletion enhances osteoclast differentiation in vitro 
A decrease in bone density and strength could occur via an increase in bone 
resorption by osteoclasts, a decrease in bone formation by osteoblasts, or a 
combination of the two. To determine the impact of Rad deletion on osteoclast 
differentiation, mononuclear cells were isolated from the spleens of WT and Rad-
/- mice and treated with M-CSF and RANKL to stimulate their differentiation 
toward multinucleated osteoclasts [62]. Staining for tartrate-resistant acid 
phosphatase (TRAP) and counting TRAP+ multinucleated cells (MNCs) indicated 
that loss of Rad significantly enhanced osteoclast differentiation in vitro (Figure 
3). 
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Figure 3. In vitro osteoclast differentiation is enhanced in the absence of 
Rad 
 
Figure 3. Representative images and quantification of tartrate-resistant acid 
phosphatase (TRAP) stained osteoclasts derived from spleen cells.  The number of 
TRAP-positive multinucleated cells (MNCs, at least 3 nuclei) was counted in each well of 
a 24-well plate. N=3 animals per genotype, male, 2 months of age, *p<0.05 compared to 
WT by Student’s t test. 
3.4 Lower osteoclast surface in Rad-/- femora  
We next performed TRAP staining of WT and Rad-/- femora to evaluate 
osteoclast numbers in vivo.  Osteoclast surface was unchanged in male Rad-/- 
animals, and a small but significant decrease in osteoclast surface was observed 
in the distal femora of female Rad-/- mice compared to WT (Figure 4). These 
data suggest that, despite the increase in in vitro osteoclastogenesis that we 
have observed, the low bone density observed in Rad-/- mice may not arise solely 
from increased osteoclast numbers. 
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Figure 4. Modest decrease in osteoclast surface in the absence of Rad 
 
 
 
Figure 4. Tartrate-resistant acid phosphatase (TRAP) staining of WT and RadKO distal 
femur thin sections and corresponding quantification of the percentage of the bone 
surface occupied by osteoclasts (Oc.S/BS). N=5-8 mice per group, 4 months of age.  
* p<0.05 compared to WT by Student’s t test. 
3.5 Lower bone formation rate in Rad-/- femora 
The reduction in osteoclast surface in Rad-/- femora suggested that the low bone 
mass phenotype might involve more than reduced osteoclast numbers and 
motivated us to ask whether Rad deletion might also alter osteoblast activity.  To 
test this notion, we used dynamic histomorphometry to determine the rate of 
bone formation in WT and Rad-/- femora in vivo.  In trabecular bone at the distal 
femur, we observed a significantly lower mineral apposition rate, but a higher 
percent mineralizing surface in Rad-/- femora compared to WT controls (Figure 5, 
Table 3).  The latter observation may arise in part due to the significant decrease 
in total trabecular bone surface at the distal femora of Rad-/- mice compared to 
WT (Figure 5A).  Normalization of MAR and MS/BS results in a downward trend 
in bone formation rate (BFR/BS) in trabecular bone of Rad-/- animals compared to 
WT (Figure 5B, Table 3).  
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We also measured these parameters in cortical bone. Consistent with the CT 
data, histology indicated a significantly lower cortical bone area at the mid-
diaphysis of Rad-/- femora compared to WT.  The mineralizing surface (MS/BS) 
and bone formation rate (BFR/BS) at the periosteal surface of Rad-/- femur 
diaphyses were significantly lower than in WT, and the periosteal mineral 
apposition rate (MAR) also trended downward in Rad-/- femora (Figure 5B, Table 
3).  These same measures at the endocortical surface of the femur diaphysis 
trended downward in Rad-/- animals but did not reach significance (Table 3).  
Overall, these data suggest that a decrease in osteoblast function may give rise 
to the lower bone mass observed in Rad-/- mice.   
Figure 5. Lower bone formation rate in Rad-/- femora 
 
 
Figure 5. A) Representative images of calcein double labeling in distal femur trabecular 
bone of WT and RadKO mice (10X). B) Mineral apposition rate (MAR), mineralizing 
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surface (MS/BS), and bone formation rate (BFR/BS) in the cortical bone (periosteal 
surface) and trabecular bone of WT and RadKO mice. N=5 mice per genotype, female, 4 
months of age  * p<0.05, ** p<0.01 compared to WT by Student’s t test. 
 
Table 3. Histomorphometry 
 
Distal Femur Wildtype (N=5) Rad-/- (N=5) 
Trabecular MAR 
(m/day) 
 
3.508 +/- 0.256 
 
2.520 +/- 0.183 * 
Trabecular MS/BS (%) 36.59 +/- 1.42 45.17 +/- 0.64 ** 
Trabecular BFR/BS 
(m3/m2/year) 
 
470.00 +/- 41.68 
 
416.95 +/- 35.96 
Femur Diaphysis Wildtype (N=5) Rad-/- (N=5) 
Ct.Ar (mm) 0.923 +/- 0.024 0.737 +/- 0.014 *** 
Periosteal MAR (m/day) 1.008 +/- 0.074 0.780 +/- 0.080 
Periosteal MS/BS (%) 54.95 +/- 4.81 39.48 +/- 2.29 * 
Periosteal BFR/BS 
(m3/m2/year) 
 
204.75 +/- 28.70 
 
114.34 +/- 17.10 * 
Endocortical MAR 
(m/day) 
 
1.075 +/- 0.086 
 
0.928 +/- 0.058 
Endocortical MS/BS (%) 75.95 +/- 4.01 69.04 +/- 4.67 
Endocortical BFR/BS 
(m3/m2/year) 
 
299.13 +/- 32.78 
 
237.54 +/- 30.37 
* p<0.05, ** p<0.01, *** p<0.001 compared to WT using Student’s t test 
 
3.6 Rad-/- calvarial osteoblast function is blunted in vitro 
To characterize the contribution of Rad GTPase signaling to osteoblast 
differentiation and function in vitro, the phenotype of osteoblasts derived from 
neonatal WT and Rad-/- calvaria was examined.  Immunoblot analysis confirmed 
Rad expression in this cell population (Figure 6A).  Consistent with the in vivo 
decrease in bone formation, osteoblast differentiation was impaired in Rad-/- 
calvarial cells as shown by a reduction in alkaline phosphatase activity, an 
enzymatic marker of osteoblast maturation (Figure 6B), and a significant 
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decrease in mineralization as indicated by Alizarin Red S staining (Figure 6C) 
following osteogenic induction. Together these data indicate that osteoblast 
development and/or function is diminished in the absence of Rad.   
Figure 6. Less mineralization in Rad-/- osteoblasts in vitro. 
 
 
Figure 6. A) Representative immunoblot of WT and RadKO calvarial osteoblast lysates 
confirms Rad expression in these cells. N=3 isolations per genotype. B) Representative 
images of WT and RadKO primary calvarial osteoblasts stained for alkaline phosphatase 
activity after 7 days in osteogenic media. N=3 isolations per genotype. C) 
Representative images of Alizarin Red S staining of WT and RadKO primary osteoblast 
monolayers after 28 days in osteogenic media. Staining was quantified by solubilization 
of the stain in acetic acid, neutralization, and optical density measurement at 405 nm. 
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N=3-4 isolations per genotype. ** p<0.01 compared to WT by Student’s t test. D) 
Osteoblast marker gene expression from microarray analysis of WT and RadKO primary 
osteoblasts. N=2 isolations per genotype. E) RT-PCR analysis of MGP expression 
confirms microarray result. N=3 isolations per genotype. 
3.7 Higher expression of matrix Gla protein in Rad-/- calvarial osteoblasts 
To examine the molecular mechanisms underlying the decrease in osteoblast 
function upon Rad loss, microarray analysis was performed to compare the gene 
expression profile of naïve calvarial osteoblasts from WT and Rad-/- mice. 
Surprisingly, Rad deficiency had no effect on the expression of the canonical 
osteoblast marker genes Runt-related transcription factor 2 (Runx2), osteocalcin 
(Bglap), or type I collagen (Col1a1) (Figure 6D).  Expression of the osteogenic 
transcription factor osterix (Sp7) and of alkaline phosphatase (Alpl) trended 
downwards but did not reach significance (Figure 6D). Instead, our profiling data 
indicated that matrix Gla protein (Mgp), a 15-kDa secreted protein that was 
initially isolated and identified from demineralized bovine bone and has since 
been found to inhibit bone mineralization [64-66], is markedly increased in Rad-/- 
calvarial osteoblasts compared to WT (+11.28-fold) (Figure 6D). This increase in 
matrix Gla protein (MGP) expression in Rad-/- osteoblasts was confirmed by RT-
PCR (Figure 6E).   
3.8 Rad-/- calvarial osteoblasts show a striking adipogenic phenotype 
During the course of culturing primary calvarial cells, we unexpectedly observed 
a dramatic increase in the number of cells that appeared to have lipid droplets in 
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the Rad-/- osteoblast preparations after ten days in culture when compared to WT 
osteoblasts.  This observation, coupled with published work indicating that MGP 
not only inhibits mineralization but that its secretion increases ~30-fold during the 
in vitro differentiation of human pre-adipocytes [67], suggested that lower 
osteogenesis following Rad deletion might be linked to increased adipogenic 
differentiation.  To test this possibility, WT and Rad-/- calvarial osteoblast 
monolayers were stained with Oil Red O (ORO) to confirm that these structures 
were lipid droplets. Consistent with a potential role for Rad in inhibiting 
adipogenesis, the number of ORO-positive cells was significantly higher in Rad-/- 
calvarial cultures compared to WT (Figure 7A). 
3.9 Increased BMAT at the distal femora of Rad-/- mice 
The significant increase in adipogenesis observed in primary Rad-/- calvarial 
osteoblast cultures under normal growth conditions suggested that Rad 
deficiency might alter the in vivo balance of osteoblasts and adipocytes in the 
bone marrow compartment. Von Kossa/MacNeal’s tetrachrome staining of WT 
and Rad-/- distal femora was performed to evaluate the overall cell distribution 
and revealed a significant increase in BMAT at the Rad-/- distal femur compared 
to WT (Figure 7B).  Rad deletion resulted in significantly higher adipocyte 
numbers as well as significantly larger adipocyte size compared to WT (Figure 
7B).  Notably, reexamination of TRAP-stained distal femora (Figure 3) was 
consistent, with unstained round structures resembling adipocytes frequently 
observed in Rad-/- femora. 
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Figure 7. Loss of Rad confers an adipogenic phenotype 
 
Figure 7. A) Representative images of WT and RadKO primary calvarial osteoblasts 
stained with Oil Red O after 14 days in mineralizing conditions. The number of ORO-
positive cells was counted for 3 random fields per isolation. N=3-4 isolations per 
genotype. B) Von Kossa/MacNeal’s staining of thin sections from WT and RadKO distal 
femora. Number of adipocytes per 20X field and the average adipocyte diameter in 
pixels were quantified. N=5 mice per genotype, female, 4 months of age. * p<0.05, ** 
p<0.01 by Student’s t test.  
3.10 Total body fat percentage is unchanged in Rad-/- mice 
To determine whether Rad loss results in a global alteration in adipogenesis, we 
weighed and performed EchoMRI body composition analysis on 4-month-old WT 
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and Rad-/- mice. These analyses showed that Rad-/- mice weigh less than WT 
littermates, but we observed no significant change in body fat percentage upon 
Rad deletion in either male or female mice (Figure 8); thus, the increase in 
adipogenesis in Rad-/- mice appears to be specific to BMAT. 
Figure 8. No change in lean or fat mass percentage in Rad-/- mice 
 
Figure 8. EchoMRI analysis of body composition of WT and RadKO mice indicates no 
change in lean or fat mass percentage.  N=8 WT male, 9 RadKO male, 21 WT female, 
11 RadKO female mice, 4 months of age. 
 
3.11 Reduction in Rad levels following adipogenic induction of calvarial 
osteoblasts  
Rad gene expression increases following lithium stimulation of mesenchymal 
stem cells, which enhances osteogenic differentiation, and Rad silencing has 
been shown to attenuate osteogenic priming [36].  These data prompted us to 
examine whether Rad expression is altered in primary calvarial cells upon 
adipogenic differentiation.  Treatment with adipogenic media for one week 
resulted in the accumulation of ORO+ lipid droplets in WT calvarial cultures (data 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
not shown), as well as a reduction in alkaline phosphatase staining resembling 
that seen in Rad-/- cultures without adipogenic stimulation (Figure 9A).  
Adipogenic treatment also resulted in a significant rise in MGP gene expression 
(Figure 9B) and a significant reduction in endogenous Rad protein levels (Figure 
9C) in WT calvarial osteoblasts.  Taken together, these data suggest that 
dynamic control of Rad may play a role in directing differentiation towards the 
osteogenic versus adipogenic lineages.  
Figure 9. Adipogenic induction results in lower endogenous Rad levels 
Figure 9. A) Representative images of alkaline phosphatase activity in WT and RadKO 
primary osteoblast monolayers following 7 days in osteogenic (OM) or adipogenic (AM) 
media. N=3 isolations per genotype. B) RT-PCR analysis of MGP expression levels 
normalized to 18S RNA. RNA was isolated from WT primary osteoblasts after 3 days in 
growth (GM) or adipogenic (AM) media. N=3 isolations. C) Western blotting of WT 
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osteoblast lysates after 7 days in growth (-) media or adipogenic (+) media. N=3 
isolations. * p<0.05 by Student’s t test. 
 
4. Discussion 
Bone is a dynamic tissue that undergoes continuous remodeling throughout life 
in response to changing demands on the skeleton and in order to maintain 
mineral homeostasis.  Dysregulation of the bone remodeling process is one 
characteristic of age-related osteoporosis.  In addition to low bone mass, 
osteoporosis is often characterized by an increase in bone marrow adiposity [68].  
Osteoblasts and adipocytes share a common mesenchymal stem cell precursor, 
but the mechanisms by which these precursors are marked for an adipogenic 
versus an osteogenic cell fate have not been fully elucidated. In this study, we 
performed the first analysis of the bone physiology of Rad-/- mice and 
demonstrated that genetic loss of Rad GTPase results in low bone mass 
accompanied by a dramatic expansion in bone marrow adipose tissue (BMAT) 
that is similar to the presentation of age-related osteoporosis in humans.  We 
also showed that Rad is significantly down regulated during the adipogenic 
differentiation of primary calvarial cells, suggesting that Rad signaling may play a 
previously unrecognized role in directing osteogenic versus adipogenic 
differentiation. 
Following the report of a requirement for Rad function in lithium-mediated 
osteogenic priming of MSCs [36], we hypothesized that global Rad-/- mice would 
have lower bone density than WT controls, which we confirmed by CT analysis.  
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Further evaluation of these bones to examine their mechanical properties 
revealed that while Rad-/- femora have significantly lower strength and stiffness, 
which would typically render them more susceptible to fracture, they also have 
significantly longer displacement than femora from WT controls.  Hence, Rad-/- 
femora are simultaneously weaker and more elastic, bending under smaller loads 
than WT but not overtly fracturing. Both collagen and water provide plasticity to 
bone [69], and the contribution of these variables to the Rad-/- mechanical 
phenotype could be explored in the future.   
Bone dynamics are controlled by the coordinated actions of osteoclasts and 
osteoblasts [70], and we sought to define the cell type(s) responsible for the 
lower bone density in Rad-/- mice.  Despite the observation of an increase in 
osteoclast differentiation in Rad-/- cells in vitro (Figure 5.4), osteoclast surface is 
not higher in Rad-/- distal femora in vivo at four months of age (Figure 5.5).  
These data tend to suggest that increased bone resorption is not the only 
mechanism responsible for the low bone mass seen in Rad-/- animals. Future 
studies to define levels of bone resorption markers and analysis of the bone 
density and osteoclast surface area of WT and Rad-/- femora from younger and 
older mice are needed to better inform the phenotype that we have observed.  
Additional work is also needed to understand the role of Rad in osteoclast 
differentiation. 
Analysis of osteoblast function in vivo and in vitro suggested that bone formation 
is impaired in Rad-/- mice.  The bone formation rate was significantly lower at the 
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periosteal surface of cortical bone and trended downwards at the endocortical 
surface as well as in trabecular bone, indicating that Rad loss might result in 
decreased osteoblast differentiation and/or function.  In vitro calvarial osteoblast 
assays corroborated this notion, as our studies indicated lower alkaline 
phosphatase activity and decreased mineralization in Rad-/- calvarial cultures 
following osteogenic induction compared to WT.  Further studies, including 
differentiation studies using MSCs, are currently underway to determine whether 
the loss of Rad impacts osteoblast differentiation, function, or both.  
Surprisingly, we did not see a change in the expression of canonical osteoblast 
marker genes in Rad-/- calvarial cells, as would be expected if osteoblast 
development was hindered in the absence of Rad.  In part this might arise from 
our study design, using freshly isolated calvarial cells prior to osteogenic 
induction.  It will be important to determine whether Rad deletion hinders this 
gene expression program following osteogenic induction.  Our microarray 
analysis did, however, reveal a robust increase in matrix Gla protein (MGP) 
expression in Rad-/- calvarial cells compared to WT.  MGP up-regulation may 
provide a novel mechanism for the decrease in osteogenesis as well as the 
increase in adipogenesis observed upon Rad deletion.  MGP has been shown to 
prevent mineralization in the osteoblast-like cell line MC3T3-E1 [65, 66].  In 
keeping with its role as an inhibitor of mineralization, transgenic mice 
overexpressing MGP in osteoblasts have low bone density [71], and MGP-
knockout mice exhibit profound calcification of the aorta and other arteries, as 
well as inappropriate calcification of cartilaginous structures like the growth plate 
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and the tracheal rings [72, 73].  Interestingly, not only does MGP inhibit 
mineralization, but its secretion is robustly increased during adipocyte 
differentiation, second only to the body fat regulatory hormone leptin [67], and we 
observed induction of MGP gene expression following adipogenic differentiation 
of WT cells.  Thus, the elevation in MGP gene expression in Rad-/- osteoblasts is 
likely important to the overall phenotype of increased adipogenesis at the 
expense of osteogenesis.   
Our finding of a change in the extracellular matrix protein MGP expression in 
Rad-/- calvarial osteoblasts, along with the report that Rad loss drives cardiac 
fibrosis via changes in extracellular matrix [29], suggests that one role for Rad 
beyond calcium channel control is regulation of the ECM. However, it is 
interesting that Rad loss appears to drive distinct gene profiles in different 
tissues.  In the heart, Rad has been found to inhibit C/EBP- activity to promote 
altered gene expression [29].  One possibility that we are currently exploring is 
that Rad loss in mesenchymal progenitors may alter C/EBP function, or the 
function of another transcription factor, to favor adipogenesis. Indeed, C/EBP 
transcriptional activity plays an important role in the early stages of adipocyte 
differentiation [74]. Studies are underway to determine whether Rad function is 
required for osteogenic differentiation of MSCs during adult bone homeostasis 
via inhibition of C/EBP family proteins, with the lack of Rad function promoting 
adipogenesis through enhanced C/EBP-dependent transcription.  
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The observation that Rad deletion increases bone marrow adiposity but not total 
body fat is intriguing.  BMAT represents a significant fraction of total body 
adipose in humans, yet its origin and physiological functions remain to be fully 
characterized [75].  Marrow adipose has gained recent interest as a distinct fat 
depot that appears to have roles regulating bone homeostasis, hematopoiesis, 
and metabolism [76].  It is well known that adipokines and free fatty acids 
released by adipocytes can modulate bone remodeling and hematopoiesis [77].  
BMAT quantity is associated with bone density loss in aging, menopause, and 
other metabolic conditions [39, 68, 78]. Indeed, BMAT has the potential to 
contribute to both local and systemic metabolic processes [77].  Notably, a 
growing cancer literature has linked Rad to regulation of tumor metabolism [79-
82].  The increase in BMAT, but not of peripheral fat, in Rad-/- animals suggests 
that Rad function may serve as a novel regulator of BMAT development and 
regulation.  This possibility is supported by a study showing that Rad protein 
levels in human skeletal muscle are correlated with measures of obesity and 
resting metabolic rate [83]. 
Unraveling the pathways that regulate the bifurcation between osteogenic and 
adipogenic differentiation is critical to understanding the disease progression of 
osteoporosis and identifying new therapies, as a shift in this balance favoring 
adipogenesis at the expense of osteogenesis may contribute to the increase in 
BMAT that accompanies low bone density in osteoporotic patients.  Our 
observation that adipogenesis is correlated with a reduction in endogenous Rad 
protein levels, coupled with the report that Rad expression is up-regulated during 
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osteogenic priming of MSCs [36], suggests that Rad levels may be dynamically 
regulated during differentiation as a means of regulating cell fate, with higher 
expression promoting osteogenesis and lower expression promoting 
adipogenesis.  Given that Rad expression is changed in other settings, including 
heart failure [19, 55], diabetes [1], and cancer [79-82, 84-88], identifying the 
molecular mechanisms whereby Rad levels are regulated is an important future 
goal.  Unlike most Ras-related small GTPases, Rad activity has not been shown 
to be controlled by classical GTP/GDP cycling [7]; therefore, alterations of total 
Rad levels may represent a novel means of regulation in a number of 
physiological settings.  Cellular regulation of Rad function remains poorly 
characterized, and future studies will be aimed at determining whether signaling 
pathways known to direct bone marrow mesenchymal cell fate, such as 
parathyroid hormone [89], bone morphogenetic protein [90], and Wnt signaling 
[91, 92], impact Rad expression and/or function.  We are in the process of 
generating a conditional Rad-knockout mouse, which will permit detailed 
mechanistic analysis of the impact of selective Rad loss on osteoblast and 
adipocyte lineages . 
5. Conclusions 
Rad GTPase plays an important, previously uncharacterized role in the 
regulation of bone homeostasis.  Deletion of Rad in mice results in low bone 
density and gives rise to femora that are simultaneously weaker and more 
elastic. Analysis of this unique osteopenic phenotype demonstrated that Rad 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
deficiency results in reduced rates of bone formation in vivo, lower in vitro 
osteoblast function, and higher rates of in vitro osteoclastogenesis. Additional 
studies are needed to characterize the molecular mechanism that underlies 
these changes.  Moreover, higher BMAT levels are observed within Rad-/- femora 
without obvious expansion of peripheral adipose tissue, and adipocytes 
spontaneously arise in primary cultures from Rad-/- calvaria. These data suggest 
that Rad may alter osteogenic versus adipogenic lineage commitment, potentially 
via regulation of matrix Gla protein expression.  Importantly, we show that 
endogenous Rad levels are decreased following adipogenic treatment of calvarial 
cells, complementing the previously reported increase in Rad expression during 
osteogenesis [36].  Taken together, these observations implicate Rad GTPase as 
a novel regulatory protein whose levels can be dynamically modulated to control 
the balance of osteogenesis and adipogenesis, and as such, studies into the 
mechanism of Rad action and regulation may present potential targets for 
osteoporosis research. 
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Highlights 
 Rad GTPase deficiency in mice results in osteopenia, altering both 
osteoblast and osteoclast differentiation in vitro. 
 Rad loss promotes in vivo bone marrow adipose tissue accumulation and 
stimulates in vitro adipogenesis of primary calvarial osteoblasts. 
 Rad loss increases the expression of matrix Gla protein, an inhibitor of 
mineralization, without altering canonical osteoblast gene expression. 
 Adipogenesis results in reduced endogenous Rad, suggesting a potential 
linkage between Rad levels, bone density, and bone marrow adiposity. 
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